Healthcare utilisation · Norwegian citizens taking one of the following drugs: citalopram (depression), omeprazol (antiulcer), cetirizin (allergy), loratadin…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health outcomes · Norwegian citizens taking one of the following drugs: citalopram (depression), omeprazol (antiulcer), cetirizin (allergy), loratadin…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · Norwegian citizens taking one of the following drugs: citalopram (depression), omeprazol (antiulcer), cetirizin (allergy), loratadin…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
CI: Confidence interval · Norwegian citizens taking one of the following drugs: citalopram (depression), omeprazol (antiulcer), cetirizin (allergy), loratadin…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Drug use · Norwegian citizens taking one of the following drugs: citalopram (depression), omeprazol (antiulcer), cetirizin (allergy), loratadin…
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Drug prices · Norwegian citizens taking one of the following drugs: citalopram (depression), omeprazol (antiulcer), cetirizin (allergy), loratadin…
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Drug expenditure · Norwegian citizens taking one of the following drugs: citalopram (depression), omeprazol (antiulcer), cetirizin (allergy), loratadin…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of children who received DTP3 or Penta 3 by 1 year of age · children under 5 years of age
Health education may leads to higher proportion of children who received DTP3/Penta 3 by 1 year of age compared with routine care (low certainty).
1 finding from 1 review
Occurrence of vaccine‐preventable diseases · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of children who received the vaccine under study (measles) · children under 5 years of age
Engagement of community leaders probably leads to higher proportion of children who received the vaccine under study (measles) compared with routine care (moderate certainty).
1 finding from 1 review
Proportion of children under 5 years of age fully immunised with all scheduled vaccines · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Occurrence of vaccine‐preventable diseases · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cost of the intervention · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cost of the intervention · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of children who received DTP3 or Penta 3 by 1 year of age · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of children who received all recommended vaccines by 2 years of age · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of children who received the vaccine under study (BCG) · children under 5 years of age
It is very uncertain whether monetary incentives changes proportion of children who received the vaccine under study (BCG) compared with routine care (very low certainty).
1 finding from 1 review
Proportion of children who received the vaccine under study (measles/MMR) ‐ household monetary incentivef · children under 5 years of age
It is very uncertain whether monetary incentives changes proportion of children who received the vaccine under study… compared with routine care (very low certainty).
1 finding from 1 review